Literature DB >> 28258423

The effect of socioeconomic status on gross total resection, radiation therapy and overall survival in patients with gliomas.

Sayantan Deb1, Arjun Vivek Pendharkar2, Matthew K Schoen2, Sean Altekruse3, John Ratliff2, Atman Desai2.   

Abstract

Socioeconomic status (SES) is associated with survival in many cancers but the effect of socioeconomic status on survival and access to care for patients with gliomas has not been well studied. This study included 50,170 patients from the Surveillance, Epidemiology, and End Results Program at the National Cancer Institute database diagnosed with gliomas of the brain from 2003 to 2012. Patient SES was divided into tertiles and quintiles. Treatment options included radiation, surgery (gross total resection (GTR)/other surgery), and radiation with surgery. Multivariable logistic regression and Cox proportional hazards model were used to analyze data with SAS v9.4. The results were adjusted for age at diagnosis, race, sex, tumor type, and tumor grade. Kaplan-Meier survival curves were constructed according to SES tertiles and quintiles. Patients from a higher SES tertile were significantly more likely to receive surgery, radiation, GTR, and radiation with surgery (OR 1.092, 1.116, 1.103, 1.150 respectively, all p < 0.0001). This correlation was also true when patients were divided into quintiles (OR 1.054, 1.072, 1.062, 1.089 respectively, all p < 0.0001). Furthermore, the lowest SES tertiles (HR 1.258, 1.146) and the lowest SES quintiles (HR 1.301, 1.273, 1.194, 1.119) were associated with significantly shorter survival times (all p for trend <0.0001). Surgery, radiation therapy, surgery with radiation therapy, and GTR were also found to be associated with improved overall survival in glioma patients (HR 0.553, 0.849, 0.666, 0.491 respectively, all p < 0.0001). The findings from this national study suggest an effect of SES on access to treatment, and survival in patients with gliomas.

Entities:  

Keywords:  Glioma; Gross total resection; Socioeconomic disparities; Survival

Mesh:

Year:  2017        PMID: 28258423     DOI: 10.1007/s11060-017-2391-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  25 in total

1.  National Cancer Data Base survey of breast cancer management for patients from low income zip codes.

Authors:  L S McGinnis; H R Menck; H J Eyre; K I Bland; C E Scott-Conner; M Morrow; D P Winchester
Journal:  Cancer       Date:  2000-02-15       Impact factor: 6.860

2.  Health disparities are important determinants of outcome for children with solid tumor malignancies.

Authors:  Mary T Austin; Hoang Nguyen; Jan M Eberth; Yuchia Chang; Andras Heczey; Dennis P Hughes; Kevin P Lally; Linda S Elting
Journal:  J Pediatr Surg       Date:  2014-10-26       Impact factor: 2.545

3.  Socioeconomic and educational factors interference in the prognosis for glioblastoma multiform.

Authors:  Jose Carlos Lynch; Leonardo Welling; Claudia Escosteguy; Alessandra G L Pereira; Ricardo Andrade; Celestino Pereira
Journal:  Br J Neurosurg       Date:  2012-08-17       Impact factor: 1.596

Review 4.  Long-term survival with glioblastoma multiforme.

Authors:  Dietmar Krex; Barbara Klink; Christian Hartmann; Andreas von Deimling; Torsten Pietsch; Matthias Simon; Michael Sabel; Joachim P Steinbach; Oliver Heese; Guido Reifenberger; Michael Weller; Gabriele Schackert
Journal:  Brain       Date:  2007-09-04       Impact factor: 13.501

5.  Socioeconomic and demographic disparities in treatment for carcinomas of the colon and rectum.

Authors:  Juliet VanEenwyk; Joseph S Campo; Eric M Ossiander
Journal:  Cancer       Date:  2002-07-01       Impact factor: 6.860

Review 6.  Cancer disparities by race/ethnicity and socioeconomic status.

Authors:  Elizabeth Ward; Ahmedin Jemal; Vilma Cokkinides; Gopal K Singh; Cheryll Cardinez; Asma Ghafoor; Michael Thun
Journal:  CA Cancer J Clin       Date:  2004 Mar-Apr       Impact factor: 508.702

7.  Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.

Authors:  Yinzhi Lai; Chun Wang; Jesse M Civan; Juan P Palazzo; Zhong Ye; Terry Hyslop; Jianqing Lin; Ronald E Myers; Bingshan Li; Binghua Jiang; Ashwin Sama; Jinliang Xing; Hushan Yang
Journal:  Gastroenterology       Date:  2016-02-02       Impact factor: 22.682

8.  Area-based socioeconomic position and adult glioma: a hierarchical analysis of surveillance epidemiology and end results data.

Authors:  Jesse J Plascak; James L Fisher
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

9.  Socioeconomic inequalities in attitudes towards cancer: an international cancer benchmarking partnership study.

Authors:  Samantha L Quaife; Kelly Winstanley; Katie A Robb; Alice E Simon; Amanda J Ramirez; Lindsay J L Forbes; Kate E Brain; Anna Gavin; Jane Wardle
Journal:  Eur J Cancer Prev       Date:  2015-05       Impact factor: 2.497

10.  Socioeconomic status does not affect prognosis in patients with glioblastoma multiforme.

Authors:  Rebecca A Kasl; Philip R Brinson; Lola B Chambless
Journal:  Surg Neurol Int       Date:  2016-05-06
View more
  10 in total

1.  Predictors and early survival outcomes of maximal resection in WHO grade II 1p/19q-codeleted oligodendrogliomas.

Authors:  Maya Harary; Vasileios K Kavouridis; Matthew Torre; Hasan A Zaidi; Ugonma N Chukwueke; David A Reardon; Timothy R Smith; J Bryan Iorgulescu
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

2.  Glioma incidence and survival variations by county-level socioeconomic measures.

Authors:  David J Cote; Quinn T Ostrom; Haley Gittleman; Kelsey R Duncan; Travis S CreveCoeur; Carol Kruchko; Timothy R Smith; Meir J Stampfer; Jill S Barnholtz-Sloan
Journal:  Cancer       Date:  2019-06-17       Impact factor: 6.860

3.  Digital Phenotyping in Patients with Spine Disease: A Novel Approach to Quantifying Mobility and Quality of Life.

Authors:  David J Cote; Ian Barnett; Jukka-Pekka Onnela; Timothy R Smith
Journal:  World Neurosurg       Date:  2019-02-22       Impact factor: 2.104

Review 4.  Risk factors for childhood and adult primary brain tumors.

Authors:  Quinn T Ostrom; Maral Adel Fahmideh; David J Cote; Ivo S Muskens; Jeremy M Schraw; Michael E Scheurer; Melissa L Bondy
Journal:  Neuro Oncol       Date:  2019-11-04       Impact factor: 12.300

5.  Factors Explaining Socio-Economic Inequalities in Cancer Survival: A Systematic Review.

Authors:  Nina Afshar; Dallas R English; Roger L Milne
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

6.  Epidemiology and survival analyses of 333 adult glioma patients from Eastern Algeria (2008-2016).

Authors:  Sabrina Touati; Rachid Djekkoun; Mohamed El-Hadef El-Okki; Dalila Satta
Journal:  Afr Health Sci       Date:  2020-09       Impact factor: 0.927

7.  Development and Validation of the Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Patients With Synovial Sarcoma.

Authors:  Zhengqing Song; Lisha Cheng; Lili Lu; Weiqi Lu; Yuhong Zhou; Zhiming Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-04       Impact factor: 5.555

8.  Acute healthcare utilization in end-of-life among Swedish brain tumor patients - a population based register study.

Authors:  Magnus Lindskog; Torbjörn Schultz; Peter Strang
Journal:  BMC Palliat Care       Date:  2022-07-23       Impact factor: 3.113

9.  Identifying Disparities in Care in Treating Glioblastoma: A Retrospective Cohort Study of Patients Treated at a Safety-net Versus Private Hospital Setting.

Authors:  Theodore Wang; Anthony Pham; Stella Yoo; Frank J Attenello; Richard Jennelle; Naveed Wagle; Eric L Chang; Gabriel Zada
Journal:  World Neurosurg       Date:  2020-01-27       Impact factor: 2.104

10.  Long-term incidence of glioma in Olmsted County, Minnesota, and disparities in postglioma survival rate: a population-based study.

Authors:  Conor S Ryan; Young J Juhn; Harsheen Kaur; Chung-Il Wi; Euijung Ryu; Katherine S King; Daniel H Lachance
Journal:  Neurooncol Pract       Date:  2019-12-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.